Form 4: Ultralife Corp Director Thomas Saeli Increases Stake with Recent Stock Purchases

Director Thomas Louis Saeli increased his holdings in Ultralife Corp (ULBI) by purchasing 5,000 shares of common stock at an average price of $5.44.

Summary

• On May 13 and 14, 2025, Thomas Louis Saeli, a director of Ultralife Corp (ULBI), purchased a total of 5,000 shares of common stock.
• The purchases were made at an average price of $5.44 per share.
• Specifically, 2,995 shares were bought on May 13, 2025, at $5.4316 per share, and 2,005 shares were bought on May 14, 2025, at $5.4525 per share.
• Following these transactions, Saeli directly owns 85,000 shares of Ultralife Corp.
• The transaction was reported on a Form 4 filing with the SEC.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. Insider buying can be a positive signal, but it's a relatively small transaction and doesn't provide definitive insight into the company's overall health.

Positives

• A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Insider transactions are closely monitored as they can provide insights into a company's prospects, although they don't always predict future performance.

Stakeholder Impact

• The stock purchase could have a minor positive impact on shareholder sentiment.

Key Dates

Keywords

Ultralife Corp, ULBI, Thomas Saeli, Director, Stock Purchase, Form 4, SEC Filing, Beneficial Ownership